News, Media & Events
Keep Up To Date With MAC
Latest Posts
MAC Clinical Research and Kariya Pharmaceuticals Celebrate Successful Completion of KP405 Phase I SAD Study
MAC Clinical Research is proud to announce the successful completion of the single ascending dose (SAD) phase of the first-in-human
Partnering with participants: how MAC champions inclusivity and public involvement
At MAC, patients and volunteers are more than participants – they are partners in everything we do. Their insights, experiences,
Comparative evaluation of swabbing sites for Omicron variant detection in PCR testing
We are pleased to share a recent publication in conjunction with the UK Health Security Agency (UKHSA) and insights from
Did you know MAC has eight UK Phase 1 sites?
MAC Clinical Research’s Manchester site is an MHRA audited and accredited Phase I centre located within and supported by the
Maintaining Sustainability and Inclusion Through Vendor Diversity
As well as working towards being a more sustainable company, there is a big drive for us to pass this
Successful dosing of first cohort in phase 1 study for Parkinson’s drug
MAC Clinical Research and Kariya Pharmaceuticals are pleased to share the successful dosing of the first cohort in a phase
Get to Know MAC: New Corporate Video Showcases Our Services and Capabilities
We are excited to release a new corporate video that provides a comprehensive overview of our services and capabilities. The
MAC joins the United Nations Global Compact
MAC Clinical Research is pleased to announce that we have joined the United Nations Global Compact initiative — a voluntary
12 common mistakes to avoid when planning your clinical trial
Clinical trials are a costly business, but with trial quality being so critical to patient safety and data integrity, getting
Clinical Trials Day 2024: The Trailblazers Among Us
Join us on 20th May to celebrate Clinical Trials Day! A day when the clinical research industry comes together to
Dementia Action Week 2024 and MAC’s legacy of free memory clinics
Dementia is a complex condition that causes a decline in cognitive abilities and interferes with daily life. It affects memory,
Understanding stress and the impact it can have on mental health
April is Stress Awareness Month and a perfect opportunity to reflect on the stress in our lives and how we
MAC Clinical Research grows its global site network with the acquisition of Intelligent Clinical from the Niche CRO Group
MAC Clinical Research (MAC) is proud to announce the acquisition of Intelligent Clinical, a clinical research site that specialises in
UK Government calls for better menopause support
In a recent 12-month progress report, the UK Government announced that it recognises women’s health, and particularly menopause, as an
Investing in people: Dr. Thuraya Al-Rihaymee’s path through clinical research
This week is Healthcare Science Week, an annual celebration of the many careers in healthcare science. Every year, this week
Are smaller to midsize Clinical Research Organisations (CROs) the way forward for biotech and pharma?
In comparison to their larger counterparts, smaller to midsize CROs can offer several advantages when it comes to conducting clinical
UK advisory body issues rapid response on psychedelics for anxiety
The UK’s independent Parliamentary Office of Science and Technology (POST) has issued a rapid response on psychedelic-assisted therapy for anxiety
Selecting the Right Contract Research Organisation (CRO) for Your Clinical Trial
A Contract Research Organisation (CRO) is a company contracted to provide day-to-day clinical research support to various organisations, such as
MAC has CIR approval in France
We are delighted to announce that MAC Clinical Research has received approval for the French Research Tax Credit (Crédit d’impôt
Race Equality Week 2024
Race Equality Week (5-11 February) is an annual UK-wide movement that unites hundreds of thousands of organisations and individuals to
MAC receives Bronze medal from EcoVadis for sustainability performance
We are proud to announce that MAC Clinical Research has received a bronze medal from EcoVadis, the world’s most trusted
The Evolving Role of Psychedelics in the treatment of Mental Health Disorders
As society continues to address the complexities of mental health issues, the therapeutic use of psychedelics is becoming more widely
Our commitment to a sustainable and ethical future
At MAC Clinical Research, we take our Corporate Social Responsibility (CSR) very seriously. Our commitment is multifaceted and extends throughout
A year in review – Reflecting on 2023
As we come closer to the end of the year, I want to take the opportunity to reflect on 2023
Diversity in Clinical Research: Tailoring MAC’s Studies for Inclusivity
At MAC, we consistently prioritise subject diversity in the trials we run and manage. We highly value this commitment and,
How can advancements in research help us better understand menopause and provide personalised treatments for managing symptoms?
With insight from Dr Abiramy Yogendran Menopause is a natural biological process that marks the end of a woman’s reproductive
Insights from PHUSE EU Connect 2023
Last week we attended the PHUSE EU Connect 2023 conference in Birmingham from 5 to 8 November. The conference was
Insights from AusBiotech 23
At the beginning of November, our Vice President of Global Proposals, Jude Warburton attended AusBiotech 2023 in Brisbane, Australia. This
MHRA approves Clinical Trial for lead Parkinson’s drug KP405
Kariya Pharmaceuticals has received approval from the MHRA for their Clinical Trial Application (CTA) related to their leading Parkinson’s drug
Understanding Alzheimer’s Disease
Alzheimer’s Disease (AD) is a complex and pervasive condition that affects the central nervous system (CNS) of millions of lives
Psoriasis: Understanding the common skin condition and available solutions
Psoriasis is a chronic skin disease that affects millions of people worldwide causing uncomfortable and itchy scaly patches primarily on
Accelerate your study with our range of unique scientific techniques
Did you know we provide an array of scientific solutions for our sponsors? One of these bespoke and highly interesting
“Loneliness is the absence of the other, aloneness is the presence of oneself” – Osho
Social connections are vital for our health and wellbeing. With the advent of the internet, smartphones, and social media, it’s
The Association of Clinical Research Professionals Philadelphia Chapter’s 2023 Inaugural Meeting
Jessica Baskin Taylor, MAC’s Director of Operations for North America, has been instrumental in the local team that is reviving
We’re Celebrating Clinical Trials Day!
Saturday 20th May is Clinical Trials Day, a day where the clinical research industry comes together to celebrate the value
Fibromyalgia – Living with Chronic Pain
Imagine living life with persistent pain that spreads throughout your body and feeling constantly drained. Fibromyalgia is a common condition
Can we improve how we capture data in psychedelic trials?
Read our white paper to find out more Last month we attended the 2023 CDISC Europe Interchange where MAC Principal
MAC Clinical Research now incorporated in Australia
To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has
MAC enters partnership with Kariya Pharmaceuticals
MAC enters partnership with Kariya Pharmaceuticals with the commencement of Phase I trial for Parkinson’s drug. We are excited to
Clinical research continues to bring hope to Parkinson’s patients
Parkinson’s disease (PD) is a progressive movement disorder of the nervous system. Like a fingerprint, disease presentation is different in
MHRA announce overhaul of trial regulation which will streamline clinical trial approvals
At MAC, we welcome the recent update from the MHRA announcing that they will streamline clinical trial approvals in its
Can the increase in psychedelic studies change how we look at the data?
Martyn Deverell, Principal SAS Programmer at MAC Clinical Research will be speaking at the 2023 CDISC Europe Interchange taking place
Raising awareness of sickle cell disease
As part of Rare Disease Day 2023, we want to highlight the work we are doing in Sickle cell disease.
First participant dosed in first-in-human Phase I clinical trial of DMT-based drug
We are excited to share that our Early Phase Unit in Manchester dosed the first participant in Small Pharma’s first-in-human
Head of Data Management selected as finalist for Association for Clinical Data Management Award
We’re proud to share that Hannah Gillis, Head of Data Management has been selected as a finalist for this year’s
Commemorating the International Day of Women and Girls in Science
In recognition of the International Day of Women and Girls in Science on February 11th, I had the opportunity to
What can we do about the placebo response in clinical trials?
The placebo response or the placebo effect. We hear about it a lot, but what happens in practise? Let’s unravel
Celebrating the women in MAC to mark the International Day of Women and Girls in Science
With International Day of Women and Girls in Science taking place in February, we want to showcase some of the
Our expert weighs in on the relationship between alcohol and ED
At MAC we have expertise in a wide range of different areas including Men and Women’s Health. One of these
A proud year: Looking back on 2022
As we approach the end of the year, it’s only natural to reflect on the previous 12 months, whether from
Keeping the patient at the heart of our research
Keeping the patient at the heart of our research: My take-homes from speaking at the C3 Summit discussing inclusivity and
MAC Clinical Research appointed to conduct psychedelic trial for Major Depressive Disorder (MDD)
SmallPharma, a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions has enlisted MAC to support a new
Continuing our legacy for more than 30 years with our free memory clinics
At MAC, we have a proud history of establishing one of the UK’s first ever memory clinics back in 1988.
Could psychedelic research be a promising new step in treating mental health disorders?
The next generation of treatment? Could psychedelic research be a promising new step in treating mental health disorders like depression,
MAC receives recognition by BritishAmerican Business (BAB) as part of Transatlantic Growth Campaign
The Transatlantic Growth campaign (TAG) is an annual campaign that highlights and celebrates businesses that demonstrate growth and investment on
MAC Featured in The Guardian Newspaper
MAC Clinical Research featured in a recent Guardian article titled: Clinical trials: how taking the pills may pay those bills.
MAC Opens US Office/Study Site
To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has
Dr Peter Dewland, Senior Director of Early Phase Research has been awarded the Faculty of Pharmaceutical Medicine President’s Medal.
MAC’s Senior Director of Early Phase Research, Dr Peter Dewland, has been awarded the Faculty of Pharmaceutical Medicine President’s Medal.
PRESS RELEASE: Initiator Pharma reports positive Phase IIa clinical data for IPED2015 in patients with severe Erectile Dysfunction
Initiator Pharma A/S, a clinical-stage biotech company that is developing a novel treatment of erectile dysfunction (ED), today announced statistically significant results on key efficacy endpoints in severe ED patients after a single administration of IPED2015. Moreover, no observations of critical adverse events were recorded.
CLINICAL TRIALS EUROPE 2019, BARCELONA
Dr John Connell (Chief Scientific Officer) and MAC’s wider team of clinical development experts attended this years Clinical Trials Europe conference in
HOT OFF THE PRESS!! – JOBS – CAREERS WITH MAC
Make a bright future for yourself with a rewarding career at MAC Clinical Research
Meetings & Conferences 2019
Teams of clinical trials experts and research scientists from MAC will be attending a broad range of meetings and conferences
PARTNERSHIPS IN CLINICAL TRIALS 2018, BARCELONA
Charlotte Chadwick will be presenting “Current challenges in running early phase studies in patients rather than healthy volunteers” at the
PHOTOS: Clinical Trials on Alzheimer’s Disease (CTAD) 2018
Photo gallery from CTAD 2018 in Barcelona on 25th October.
PRESS RELEASE: MAC Clinical Research expands its Global Site Network and access to patients in Australia and Asia Pacific regions
October 24, 2018 MANCHESTER, ENGLAND Across every clinical trial, Pharma and Biotech have a dire need to access patients in efficient
60th Annual Scientific Meeting – SAN FRANCISCO
MAC is exhibiting at the American Headache Society’s 60th Annual Scientific Meeting in San Francisco 28 June – 1 July 2018
MAC GMP Pharmacy Manufacturing Service – Pharmacy MIA(IMP) Licenced Production Unit
MAC’s GMP pharmacy manufacturing department currently supports our MHRA accredited Phase 1 research centre in Manchester and late phase dedicated
Defying Dementia – Help the fight against dementia
Defying Dementia is raising funds for Dementia research.
Dr Mark Dale Receives Honorary Membership of the Faculty of Pharmaceutical Medicine
MAC is very proud to announce that Dr Mark Dale (CEO) has been awarded Honorary Membership of the Faculty of
PRESS RELEASE: MHRA Award Accreditation for MAC’s Phase 1 Site
MAC Neuroscience Centre of excellence, the early phase division of MAC Clinical Research, has been awarded Accreditation from the Medicines and Healthcare products Regulatory Agency (MHRA).
PCT Conference 2016 – VIENNA
MAC will be exhibiting at this year’s PCT conference in Vienna 16 – 17 November 2016.
Exploratory Clinical Development World Europe 2016
MAC will be exhibiting at this year’s Exploratory Clinical Development World Congress in Berlin 26th – 27th October 2016.
Lancaster University Alzheimer’s Disease Research
MAC meets the Alzheimer’s disease research team with Dr Penny Foulds at Lancaster University.
Diary Date: American Pain Society Meeting 2016 – Austin TX
MAC’s Chief Research and Development Officer, Dr John Connell will be speaking at the 35th Annual Scientific Meeting of the
Diary Date: ECD Meeting 2016 – London
MAC is attending the Early Clinical Development (ECD) meeting in London. ECD is an open forum for exchanging knowledge between Industry, Academia
Defying Dementia
Lancaster University launched the “Defying Dementia” campaign earlier this year, in order to raise awareness of Alzheimer’s and the new drug,
Diary Date: PCT Meeting 2015 – Hamburg
The European Union’s clinical outsourcing event of the year, CCH Congress Centre in Hamburg.Come and meet us at Stand 321.
New Alzheimer’s Drug to Enter Clinical Trials
A new drug developed by Lancaster University which may help to prevent the early stages of Alzheimer’s disease is to enter clinical trials. Lancaster University has filed a patent application for the drug, and it will be progressing into clinical trials run by the north-west research company MAC Clinical Research.
MAC Wins Health & Care Business of the Year at the 2015 Red Rose Awards
MAC is delighted to announce that it has won the highly coveted Health and Care Business of the Year Award
MAC Opens Phase I Clinic in the Manchester Corridor
MAC Clinical Research has opened a new phase I/IIa clinic at Citylabs in Manchester, expanding its phase I services in
MAC Is Shortlisted For The 2014 BIONOW Technical Service Award
We are delighted to annouce that MAC has been shortlisted for Bionow’s Technical Service of the Year Award. The Bionow awards celebrate and
Dr John Connell Joins MAC As Chief Research & Development Officer
We are delighted to welcome Dr John Connell to MAC who will lead our pharmacodynamic offering. Dr Connell completed his
MAC Pain Team Presents & Consults In Buenos Aires 6-11 OCTOBER 2014
MAC’s pain experts were on hand at the 15th World Congress on Pain this week. The team met with many
MAC Co-Presents Landmark Data At Diabetes UK Professional Conference In Liverpool
THCV improves glycaemic control in Type 2 Diabetes “Diabetes is at crisis levels”: The International Diabetes Foundation calculate that 366
MAC Exhibits At The 12th Annual Partnerships In Clinical Trials Congress – Vienna
MAC had a team of Business Development personnel and Scientists at this years Partnerships in Clinical Trials Congress in Vienna.
MAC Presents Fibromyalgia Poster At EFIC 2013
MAC Clinical Research recently presented at the 8th biennial Congress of the European Federation of IASP® Chapters (EFIC 2013), which was held in Florence, Italy, 9-12 October 2013.
MAC Supports The Fylde Coast Health Mela
Members of the MAC Blackpool team were present to support the 2013 Fylde Coast Health Mela on Saturday 5th October, which was held in the Winter Gardens in Blackpool. This was the first ever health Mela to be held in the area and MAC were happy to aid its cause.
New Zealand Grants Patent for CliniSafe
New Zealand has granted CliniSafe® a Patent for concomitant drug checking over the internet. CliniSafe® won the SCRIP award 2010 for Best Technological Development in Clinical Trials.
MAC Opens New Aseptic Suite Increasing Pharmacy Offering At Flagship Research Site In Manchester UK
MAC Clinical Research has recently completed the installation of a state-of-the-art aseptic suite at its flagship research site in Manchester.
MAC Is Shortlisted For The 2012 Bionow Awards
MAC has been shortlisted for this year’s Bionow awards.
MAC – BIBA’S Finalist In 3 Categories
MAC is a finalist in 3 categories at the BIBA awards 2012. MAC is also shorlisted in the category of Service Company of the Year.
MAC’s CEO Wins Institute Of Directors Award For Business Innovation
Mark Dale, CEO of MAC Clinical Research wins and Institute of Directors Award for Innovation.
MAC Wins The Queen’s Award For Enterprise
MAC is delighted and very proud to have received the Queen’s Award in recognition of MAC’s trade achievements. The Award is a marvellous acknowledgement our Company’s business development in the clinical research industry. (Image: Her Majesty Queen Elizabeth II greets winners of the Queen’s Award
Cathy Jepson of MAC meets the Queen)
MAC Is Shortlisted For The 2011 Bionow Awards
MAC has been shortlisted for this year’s Bionow awards.
CliniSafe Wins 2010 SCRIP Award For Best Technological Development In Clinical Trials
CliniSafe® has won the 2010 SCRIP award for Best Technological Development in Clinical Trials. SCRIP Intelligence – the leading news, data and information service for the global pharmaceutical industry – hosted the 6th Annual SCRIP Awards on 4th November at London’s Grosvenor House Hotel. More than 500 people were present at the industry’s most prestigious and hotly-contested awards event.
MAC’S Cathy Jepson (Centre) Represents CliniSafe To Present Quintiles With The 2010 SCRIP Award For Best Contract Research Organisation
CliniSafe® sponsors the 2010 SCRIP Award for Best Contract Research Organisation.
Featured Posts
Categories
Follow Us
Follow MAC Clinical Research on social media to keep up to date with our latest news and updates.